Latest filing published 16 Aug 2016 for Insys Therapeutics, Inc., €79k.
No signal scores available.
Theodore H. Stanley is a declared insider of Insys Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 6 June 2016 to 16 August 2016, the count stands at 4 filings.
The open-market record consists of 2 sales worth €469k, with no purchase. The rest of the record consists of 2 option exercises.
Most recently, on 16 August 2016, the filings show an option exercise worth €79k in Insys Therapeutics, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations